FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Acs

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Gabriella Czifra; Balázs Istvan Tóth; Rita Marincsák; István Juhász; Ildikó Kovács; Peter Acs; László Kovács; Peter M Blumberg; Tamás Bíró
Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cdelta.
Geza Acs; Mei Chen; Xiaowei Xu; Peter Acs; Ajay Verma; Cameron J Koch
Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.
Geza Acs; Xiaowei Xu; Christina Chu; Peter Acs; Ajay Verma
Prognostic significance of erythropoietin expression in human endometrial carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Acs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Gabriella Czifra; Balázs Istvan Tóth; Rita Marincsák; István Juhász; Ildikó Kovács; Peter Acs; László Kovács; Peter M Blumberg; Tamás Bíró
Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cdelta.
Cellular signalling 2006;18(9):1461-72.
2004: Geza Acs; Mei Chen; Xiaowei Xu; Peter Acs; Ajay Verma; Cameron J Koch
Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.
Cancer letters 2004;214(2):243-51.
2004: Geza Acs; Xiaowei Xu; Christina Chu; Peter Acs; Ajay Verma
Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Cancer 2004;100(11):2376-86.
2004: Helga Papp; Gabriella Czifra; Eniko Bodó; József Lázár; Ildikó Kovács; Magdolna Aleksza; István Juhász; Peter Acs; Sándor Sipka; László Kovács; Peter M Blumberg; Tamás Bíró
Opposite roles of protein kinase C isoforms in proliferation, differentiation, apoptosis, and tumorigenicity of human HaCaT keratinocytes.
Cellular and molecular life sciences : CMLS 2004;61(9):1095-105.
2004: Jeewoo Lee; Su Yeon Kim; Ji-Hye Kang; Geza Acs; Peter Acs; Peter M Blumberg; Victor E Marquez
Conformationally constrained diacylglycerol (DAG) analogs: 4-C-hydroxyethyl-5-O-acyl-2,3-dideoxy-D-glyceropentono-1,4-lactone analogs as protein kinase C (PKC) ligands.
European journal of medicinal chemistry 2004;39(1):69-77.
2003: Geza Acs; Paul J Zhang; Cindy M McGrath; Peter Acs; John W McBroom; Ahmed Mohyeldin; Suzhen Liu; Huasheng Lu; Ajay Verma
Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
The American journal of pathology 2003;162(6):1789-806.
2002: Geza Acs; Paul J Zhang; Timothy R Rebbeck; Peter Acs; Ajay Verma
Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Cancer 2002;95(5):969-81.
2001: Geza Acs; Peter Acs; S M Beckwith; R L Pitts; E Clements; K Wong; Ajay Verma
Erythropoietin and erythropoietin receptor expression in human cancer.
Cancer research 2001;61(9):3561-5.
2000: Peter Acs; G Paragh
[Protein kinase C as a potential target for drug development in cancer research].
Orvosi hetilap 2000;141(32):1767-71.
2000: Peter Acs; M Beheshti; Z Szállási; Luowei Li; Stuart H Yuspa; Peter M Blumberg
Effect of a tyrosine 155 to phenylalanine mutation of protein kinase cdelta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts.
Carcinogenesis 2000;21(5):887-91.
1999: K Bögi; Patricia S Lorenzo; Peter Acs; Z Szállási; G S Wagner; Peter M Blumberg
Comparison of the roles of the C1a and C1b domains of protein kinase C alpha in ligand induced translocation in NIH 3T3 cells.
FEBS letters 1999;456(1):27-30.
1999: Larisa Y Romanova; I A Alexandrov; Mikhail V Blagosklonny; R P Nordan; Susan H Garfield; Peter Acs; P Nguyen; Jane Trepel; Peter M Blumberg; J Frederic Mushinski
Regulation of actin cytoskeleton in lymphocytes: PKC-delta disrupts IL-3-induced membrane ruffles downstream of Rac1.
Journal of cellular physiology 1999;179(2):157-69.
1999: Chaya Brodie; K Bogi; Peter Acs; Philip Lazarovici; Gyorgy Petrovics; Wayne B Anderson; Peter M Blumberg
Protein kinase C-epsilon plays a role in neurite outgrowth in response to epidermal growth factor and nerve growth factor in PC12 cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(3):183-91.
1998: Chaya Brodie; K Bogi; Peter Acs; Patricia S Lorenzo; L Baskin; Peter M Blumberg
Protein kinase C delta (PKCdelta) inhibits the expression of glutamine synthetase in glial cells via the PKCdelta regulatory domain and its tyrosine phosphorylation.
The Journal of biological chemistry 1998;273(46):30713-8.
1998: Chaya Brodie; I Kuperstein; Peter Acs; Peter M Blumberg
Differential role of specific PKC isoforms in the proliferation of glial cells and the expression of the astrocytic markers GFAP and glutamine synthetase.
Brain research. Molecular brain research 1998;56(1-2):108-17.
1998: Tamás Bíró; Chaya Brodie; S Modarres; Nancy E Lewin; Peter Acs; Peter M Blumberg
Specific vanilloid responses in C6 rat glioma cells.
Brain research. Molecular brain research 1998;56(1-2):89-98.
1998: K Bögi; Patricia S Lorenzo; Z Szállási; Peter Acs; G S Wagner; Peter M Blumberg
Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
Cancer research 1998;58(7):1423-8.
1998: Tamás Bíró; Marcus Maurer; S Modarres; Nancy E Lewin; Chaya Brodie; Geza Acs; Peter Acs; R Paus; Peter M Blumberg
Characterization of functional vanilloid receptors expressed by mast cells.
Blood 1998;91(4):1332-40.
1998: Qiming J Wang; Peter Acs; JoAnne Goodnight; Peter M Blumberg; Mischak Harald; J Frederic Mushinski
The catalytic domain of PKC-epsilon, in reciprocal PKC-delta and -epsilon chimeras, is responsible for conferring tumorgenicity to NIH3T3 cells, whereas both regulatory and catalytic domains of PKC-epsilon contribute to in vitro transformation.
Oncogene 1998;16(1):53-60.
1997: Patricia S Lorenzo; K Bögi; Peter Acs; George R Pettit; Peter M Blumberg
The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
The Journal of biological chemistry 1997;272(52):33338-43.
1997: Peter Acs; Qiming J Wang; K Bögi; A M Marquez; Patricia S Lorenzo; Tamás Bíró; Z Szállási; J Frederic Mushinski; Peter M Blumberg
Both the catalytic and regulatory domains of protein kinase C chimeras modulate the proliferative properties of NIH 3T3 cells.
The Journal of biological chemistry 1997;272(45):28793-9.
1997: Peter Acs; K Bögi; Patricia S Lorenzo; A M Marquez; Tamás Bíró; Z Szállási; Peter M Blumberg
The catalytic domain of protein kinase C chimeras modulates the affinity and targeting of phorbol ester-induced translocation.
The Journal of biological chemistry 1997;272(35):22148-53.
1997: Tamas Biro; Geza Acs; Peter Acs; S Modarres; Peter M Blumberg
Recent advances in understanding of vanilloid receptors: a therapeutic target for treatment of pain and inflammation in skin.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1997;2(1):56-60.
1997: Geza Acs; Tamas Biro; Peter Acs; S Modarres; Peter M Blumberg
Differential activation and desensitization of sensory neurons by resiniferatoxin.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(14):5622-8.
1997: Alan P Kozikowski; Shaomeng Wang; Dawei Ma; J Yao; S Ahmad; R I Glazer; K Bogi; Peter Acs; S Modarres; Nancy E Lewin; Peter M Blumberg
Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
Journal of medicinal chemistry 1997;40(9):1316-26.
1997: Qiming J Wang; Peter Acs; JoAnne Goodnight; Thomas Giese; Peter M Blumberg; Mischak Harald; J Frederic Mushinski
The catalytic domain of protein kinase C-delta in reciprocal delta and epsilon chimeras mediates phorbol ester-induced macrophage differentiation of mouse promyelocytes.
The Journal of biological chemistry 1997;272(1):76-82.
1996: J Lee; Nancy E Lewin; Peter Acs; Peter M Blumberg; Victor E Marquez
Conformationally constrained analogues of diacylglycerol. 13. Protein kinase C ligands based on templates derived from 2,3-dideoxy-L-erythro(threo)-hexono-1,4-lactone and 2-deoxyapiolactone.
Journal of medicinal chemistry 1996;39(25):4912-9.
1996: Arpad Szallasi; M Jonassohn; G Acs; Tamás Bíró; Peter Acs; Peter M Blumberg; Olov Sterner
The stimulation of capsaicin-sensitive neurones in a vanilloid receptor-mediated fashion by pungent terpenoids possessing an unsaturated 1,4-dialdehyde moiety.
British journal of pharmacology 1996;119(2):283-90.
1996: Z Szallasi; K Bogi; S Gohari; T Biro; Peter Acs; Peter M Blumberg
Non-equivalent roles for the first and second zinc fingers of protein kinase Cdelta. Effect of their mutation on phorbol ester-induced translocation in NIH 3T3 cells.
The Journal of biological chemistry 1996;271(31):18299-301.
1995: Peter Acs; Z Szallasi; Marcelo G Kazanietz; Peter M Blumberg
Differential activation of PKC isozymes by 14-3-3 zeta protein.
Biochemical and biophysical research communications 1995;216(1):103-9.
1995: Peter M Blumberg; Geza Acs; Peter Acs; L B Areces; Marcelo G Kazanietz; Nancy E Lewin; Z Szallasi
Protein kinase C in cell signaling: strategies for the development of selective inhibitors.
Agents and actions. Supplements 1995;47():87-100.